Mon, Nov 16, 2026 - Page 16
8174 indexed SquawkNews stories from this UTC day. Showing 1801-1920.
L
HEALTHY EXTRACTS INC. Q3 GROSS MARGIN 54.7%
HEALTHY EXTRACTS INC. Q3 GROSS MARGIN 54.7%
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
Gilead Expands Access to Investigational Ebola Drug Through Voluntary Licensing
Gilead said it is expanding access to investigational obeldesivir for Ebola Bundibugyo virus disease through voluntary licensing.
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
AECOM Q4 NET INCOME FROM CONT OPS USD 139.967 MILLION
AECOM Q4 NET INCOME FROM CONT OPS USD 139.967 MILLION
FX | Nov 16, 2026, 09:05 PM UTC
L
ReposiTrak Announces SPAR Group Transaction and Reports First Quarter Fiscal 2027 Results
ReposiTrak (NYSE:TRAK), an AI-powered, integrated supply chain platform, today announced financial results for the first fiscal quarter ended September 30, 2026.First Quarter Financial Highlights (three months ended Sept
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
Zeo Energy Reports Over 10% Revenue Growth and $1.3 Million Net Income in Third Quarter 2026
Quarterly revenue increased 63% sequentially from second quarter 2026 to $26.4 million Achieved oper
EARNINGS | Nov 16, 2026, 09:05 PM UTC
L
AECOM Q4 EPS USD 0.99
AECOM Q4 EPS USD 0.99
EARNINGS | Nov 16, 2026, 09:05 PM UTC
L
CONNECT BIOPHARMA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
CONNECT BIOPHARMA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 16, 2026, 09:05 PM UTC
H
INFLEQTION REPORTS THIRD QUARTER 2026 RECORD REVENUE RESULTS, ACHIEVES 30-LOGICAL-QUBIT MILESTONE AND MAINTAINS FULL-YEAR REVENUE GUIDANCE
INFLEQTION REPORTS THIRD QUARTER 2026 RECORD REVENUE RESULTS, ACHIEVES 30-LOGICAL-QUBIT MILESTONE AN
EARNINGS | Nov 16, 2026, 09:05 PM UTC
L
AIB DATA CENTERS REPORTS THIRD QUARTER 2026 RESULTS, HIGHLIGHTED BY 12-YEAR CUSTOMER AGREEMENT AND NEARLY DOUBLED CONTRACTED POWER
AIB DATA CENTERS REPORTS THIRD QUARTER 2026 RESULTS, HIGHLIGHTED BY 12-YEAR CUSTOMER AGREEMENT AND N
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
Duos Technologies Reports Third Quarter 2026 Results
Duos Technologies Reports Third Quarter 2026 Results Q3 2026 Revenue Increased 103%, Driven by Techn
EARNINGS | Nov 16, 2026, 09:05 PM UTC
L
BARFRESH FOOD Q3 REVENUE USD 5.8 MILLION
BARFRESH FOOD Q3 REVENUE USD 5.8 MILLION
EARNINGS | Nov 16, 2026, 09:05 PM UTC
L
Powell Industries Announces Fourth Quarter and Full Year Fiscal 2026 Results
Powell Industries Announces Fourth Quarter and Full Year Fiscal 2026 Results HOUSTON, Nov. 16, 2026
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
GoPro 3Q Loss/Shr 44c >GPRO
GoPro 3Q Loss/Shr 44c >GPRO
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
REPOSITRAK ANNOUNCES SPAR GROUP TRANSACTION AND REPORTS FIRST QUARTER FISCAL 2027 RESULTS
REPOSITRAK ANNOUNCES SPAR GROUP TRANSACTION AND REPORTS FIRST QUARTER FISCAL 2027 RESULTS
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
NextBoat Inc. Announces Fiscal Third Quarter 2026 Results
NextBoat Inc. Announces Fiscal Third Quarter 2026 Results WILMINGTON, NC / ACCESS Newswire / Novembe
EQUITY | Nov 16, 2026, 09:05 PM UTC
H
Exclusive: Advocates dub midterms the ‘care election’
Some exit polling suggests voters want the next Congress to focus on issues like paid leave and child care. This month’s midterms were the “care election,” according to a sweeping new report by Care Can’t Wait Action tha
GEOPOLITICS | Nov 16, 2026, 09:05 PM UTC
L
AECOM 4Q Adj EPS $1.63 >ACM
AECOM 4Q Adj EPS $1.63 >ACM
EARNINGS | Nov 16, 2026, 09:05 PM UTC
L
Connect Biopharma Reports Third Quarter 2026 Financial Results and Provides Business Update
Connect Biopharma Reports Third Quarter 2026 Financial Results and Provides Business Update — Report
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
GoPro 3Q Adj Loss/Shr 24c >GPRO
GoPro 3Q Adj Loss/Shr 24c >GPRO
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
AECOM 4Q EPS 98c >ACM
AECOM 4Q EPS 98c >ACM
EARNINGS | Nov 16, 2026, 09:05 PM UTC
L
Healthy Extracts Reports Results for Third Quarter and Nine Months 2026
Healthy Extracts Reports Results for Third Quarter and Nine Months 2026 LAS VEGAS, NV / ACCESS Newsw
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
RED CAT REPORTS Q3 2026 REVENUE GROWTH OF 22% Y/Y; YTD Q3 2026 REVENUE GROWTH OF 227% Y/Y; ANNOUNCED PUBLIC PURCHASE TO ACQUIRE STEYR MOTORS
RED CAT REPORTS Q3 2026 REVENUE GROWTH OF 22% Y/Y; YTD Q3 2026 REVENUE GROWTH OF 227% Y/Y; ANNOUNCED
EARNINGS | Nov 16, 2026, 09:05 PM UTC
L
RELIANCE GLOBAL GROUP REPORTS THIRD QUARTER 2026 NET INCOME OF $3.3 MILLION AND ADVANCES AI INFRASTRUCTURE GROWTH THROUGH OBLIVUS ACQUISITIO
RELIANCE GLOBAL GROUP REPORTS THIRD QUARTER 2026 NET INCOME OF $3.3 MILLION AND ADVANCES AI INFRASTR
MNA | Nov 16, 2026, 09:05 PM UTC
L
Barfresh Announces Third Quarter 2026 Results
Barfresh Announces Third Quarter 2026 Results Third Quarter Revenue Increased 37% Year-Over-Year to
EARNINGS | Nov 16, 2026, 09:05 PM UTC
L
Red Cat Reports Q3 2026 Revenue Growth Of 22% Y/Y; YTD Q3 2026 Revenue Growth of 227% Y/Y; Announced Public Purchase to Acquire Steyr Motors
Red Cat Reports Q3 2026 Revenue Growth Of 22% Y/Y; YTD Q3 2026 Revenue Growth of 227% Y/Y; Announced
EARNINGS | Nov 16, 2026, 09:05 PM UTC
L
Reliance Global Group Reports Third Quarter 2026 Net Income of $3.3 Million and Advances AI Infrastructure Growth Through Oblivus Acquisitio
Reliance Global Group Reports Third Quarter 2026 Net Income of $3.3 Million and Advances AI Infrastr
MNA | Nov 16, 2026, 09:05 PM UTC
L
General Fusion Reports Third Quarter 2026 Results
General Fusion Reports Third Quarter 2026 Results General Fusion became the first publicly listed fu
EQUITY | Nov 16, 2026, 09:05 PM UTC
L
Google to give Japan early access to frontier AI for cybersecurity - Nikkei. $GOOGL
Google to give Japan early access to frontier AI for cybersecurity - Nikkei. $GOOGL
NEWS | Nov 16, 2026, 09:04 PM UTC
L
Fidelis Capital Sees Yields Staying Higher for Longer
Fidelis Capital says inflation is fueling expectations for Federal Reserve rate hikes.
RATES | Nov 16, 2026, 09:04 PM UTC
L
AGM Group Holdings Names Rui Zhang CEO and CFO
Rui Zhang shall serve as AGM Group Holdings’ principal executive officer and principal financial officer.
EQUITY | Nov 16, 2026, 09:04 PM UTC
L
Google to Offer Japan Government Early Access to Latest AI Model
Google will offer Japan’s government and major infrastructure providers early access to its latest AI model, Nikkei reports.
EQUITY | Nov 16, 2026, 09:04 PM UTC
L
Moody’s Names Timothy Bhatt CIO, Adds Him to Leadership Team
Bhatt will take the newly created role effective Dec. 7 and lead enterprise technology strategy.
EQUITY | Nov 16, 2026, 09:04 PM UTC
H
Fidelis Capital: Hot October Inflation Bolsters December Fed Rate Hike Expectations
Fidelis Capital: Hot October Inflation Bolsters December Fed Rate Hike Expectations Hotter-than
CENTRAL_BANK | Nov 16, 2026, 09:04 PM UTC
L
Berkshire Hathaway Raises Delta Air Lines Stake By 12.4% To 64.5M Shares — SEC Filing
Cuts Kroger Stake By 10.3% To 35M Shares
REGULATION | Nov 16, 2026, 09:04 PM UTC
L
AGM Group CEO Bo Zhu Resigns as CEO, Strategy Chief and Director
AGM Group Holdings said Bo Zhu notified the company of his resignation from the CEO, chief strategy officer and director roles.
EQUITY | Nov 16, 2026, 09:04 PM UTC
L
Berkshire cuts Bank of America stake 5.7% to 455.9 million shares
An SEC filing says Berkshire Hathaway reduced its Bank of America stake by 5.7%, to 455.9 million shares.
EQUITY | Nov 16, 2026, 09:04 PM UTC
L
Google to Give Japan Early Access to Frontier AI for Cybersecurity
Nikkei reports Google will give Japan early access to its frontier AI for cybersecurity.
EQUITY | Nov 16, 2026, 09:04 PM UTC
L
AGM Group Names Rui Zhang CEO and Board Chair
AGM Group Holdings appointed director Rui Zhang as CEO and board chairperson.
EQUITY | Nov 16, 2026, 09:04 PM UTC
L
Berkshire Hathaway Raises Macy’s Stake to 7.5 Million Shares
A SEC filing says Berkshire Hathaway increased its Macy’s share stake by 2.6%, to 7.5 million shares.
EQUITY | Nov 16, 2026, 09:03 PM UTC
L
Safe Pro Group Q3 2026 net loss narrows 69% year-over-year to $1.54 million; Q3 revenue rises to $2.68 million year-over-year
Safe Pro Group Q3 2026 net loss narrows 69% year-over-year to $1.54 million; Q3 revenue rises to $2.
EARNINGS | Nov 16, 2026, 09:03 PM UTC
L
DARE BIOSCIENCE, INC. Q3 EPS USD -0.18
DARE BIOSCIENCE, INC. Q3 EPS USD -0.18
EARNINGS | Nov 16, 2026, 09:03 PM UTC
L
Berkshire Hathaway Cuts Nucor Stake by 276,976 Shares
Berkshire Hathaway decreased its Nucor holdings by 276,976 shares to 1,580,776 shares.
EQUITY | Nov 16, 2026, 09:03 PM UTC
L
Critical Metals Cash More Than Doubles After European Lithium Merger
Critical Metals’ cash more than doubled following its merger with European Lithium.
EQUITY | Nov 16, 2026, 09:03 PM UTC
M
OREZONE GOLD CORPORATION - Q3-2026 GOLD PRODUCTION OF 59,674 OZ; TOTAL SALES 56,461 OZ AT AVERAGE PRICE $4,174/OZ
OREZONE GOLD CORPORATION - Q3-2026 GOLD PRODUCTION OF 59,674 OZ; TOTAL SALES 56,461 OZ AT AVERAGE PR
COMMODITIES | Nov 16, 2026, 09:03 PM UTC
L
Dare Bioscience 3Q Rev $47,628 >DARE
Dare Bioscience 3Q Rev $47,628 >DARE
EQUITY | Nov 16, 2026, 09:03 PM UTC
L
ENANTA PHARMACEUTICALS Q4 EPS USD -0.81
ENANTA PHARMACEUTICALS Q4 EPS USD -0.81
EARNINGS | Nov 16, 2026, 09:03 PM UTC
H
*-- Earnings Flash (OMER) Omeros Corporation Posts Q3 Adjusted EPS $0.06 per Share
*-- Earnings Flash (OMER) Omeros Corporation Posts Q3 Adjusted EPS $0.06 per Share
EARNINGS | Nov 16, 2026, 09:03 PM UTC
H
Musk’s policy difficulty prevents Starlink’s South Africa entry
President Cyril Ramaphosa said Elon Musk failed to understand the impact of apartheid on Black South Africans. Elon Musk’s “difficulty in understanding” a key South African policy is the main issue preventing his Starlin
GEOPOLITICS | Nov 16, 2026, 09:03 PM UTC
L
BRIEF-Omeros Corporation Q3 EPS USD -0.79
Nov 16 (Reuters) - Omeros Corporation Q3 net income USD -57.4 million.
EARNINGS | Nov 16, 2026, 09:03 PM UTC
L
Berkshire Hathaway Raises Delta Air Lines Stake 12.4% to 64.5 Million Shares
A filing shows Berkshire Hathaway increased its Delta Air Lines stake by 12.4%, to 64.5 million shares.
EQUITY | Nov 16, 2026, 09:03 PM UTC
L
Berkshire Cuts Kroger Stake 10.3% to 35 Million Shares
A SEC filing says Berkshire Hathaway cut its Kroger shareholding by 10.3% to 35.0 million shares.
EQUITY | Nov 16, 2026, 09:03 PM UTC
L
Ton Strategy Grants CAO 187,000 Restricted Stock Units
Ton Strategy granted its chief accounting officer 187,000 restricted stock units.
EQUITY | Nov 16, 2026, 09:03 PM UTC
L
BRIEF-Omeros Corporation Q3 EPS USD -0.79
BRIEF-Omeros Corporation Q3 EPS USD -0.79 Nov 16 (Reuters) - Omeros Corporation Q3 net income USD -5
EARNINGS | Nov 16, 2026, 09:03 PM UTC
L
Safe Pro Group Reports Record Q3 2026 Revenue of $2.68 Million, Up 2,539% Year-over-Year & 101% Sequentially, with Record 79% AI Gross Margi
AVENTURA, Fla., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Safe Pro Group Inc.
EARNINGS | Nov 16, 2026, 09:02 PM UTC
L
SAFE PRO GROUP REPORTS RECORD Q3 2026 REVENUE OF $2.68 MILLION, UP 2,539% YEAR-OVER-YEAR & 101% SEQUENTIALLY, WITH RECORD 79% AI GROSS MARGI
SAFE PRO GROUP REPORTS RECORD Q3 2026 REVENUE OF $2.68 MILLION, UP 2,539% YEAR-OVER-YEAR & 101% SEQU
EARNINGS | Nov 16, 2026, 09:02 PM UTC
L
Safe Pro Group Reports Record Q3 2026 Revenue of $2.68 Million, Up 2,539% Year-over-Year & 101% Sequentially, with Record 79% AI Gross Margi
Safe Pro Group Reports Record Q3 2026 Revenue of $2.68 Million, Up 2,539% Year-over-Year & 101% Sequ
EARNINGS | Nov 16, 2026, 09:02 PM UTC
L
Kindred Ventures joins $110 million funding round for Noeri
Kindred Ventures participated in Noeri’s $110 million funding round.
EQUITY | Nov 16, 2026, 09:02 PM UTC
L
WATCH LIVE: UK's PM Burnham Speaks on Brexit
WATCH LIVE: UK's PM Burnham Speaks on Brexit
NEWS | Nov 16, 2026, 09:02 PM UTC
L
Dycom Industries to Attend BofA Securities and UBS Investor Conferences
EQUITY | Nov 16, 2026, 09:02 PM UTC
M
Windward Bio Raises $50 Million in Private Placement to Sanofi
Windward Bio raised $50 million in a private placement to Sanofi Foreign Participations.
EQUITY | Nov 16, 2026, 09:02 PM UTC
L
Omeros Corporation Reports Third Quarter 2026 Financial Results
Omeros Corporation (NASDAQ:OMER) today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2026, which include:Third Quarter and Recent Highlights“YARTEMLEA
EQUITY | Nov 16, 2026, 09:02 PM UTC
L
CervoMed Presents Interim Neflamapimod Data at CTAD 2026
The 24-week interim data showed an exposure-dependent reduction in a neurodegeneration biomarker, neurofilament light, in nonfluent variant primary progressive aphasia.
EQUITY | Nov 16, 2026, 09:02 PM UTC
L
Daré Bioscience Reports Q3 Net Loss of $3.2M, Down From $3.6M
Q3 2026 net loss was approximately $3.2M, compared with approximately $3.6M a year earlier; revenue was approximately $48K versus approximately $2.3K. The company had approximately $11.5M in cash and cash equivalents at
EARNINGS | Nov 16, 2026, 09:02 PM UTC
L
BRIEF-Interpace Biosciences Q3 Revenue USD 10.373 Million
Nov 16 (Reuters) - Interpace Biosciences Q3 gross profit USD 7.18 million.
EARNINGS | Nov 16, 2026, 09:02 PM UTC
H
Fewer Americans Will Host Thanksgiving as Inflation Reshapes Menus and Shrinks Guest Lists
LendingTree's 2026 Survey Finds Thanksgiving Hosts Expect to Spend $427 as Nearly Two-Thirds Say The
MACRO | Nov 16, 2026, 09:02 PM UTC
L
BRIEF-Enanta Pharmaceuticals Q4 Revenue USD 12.868 Million
Nov 16 (Reuters) - Enanta Pharmaceuticals Q4 net income USD -23.718 million.
EARNINGS | Nov 16, 2026, 09:02 PM UTC
L
Omeros Corporation Reports Third Quarter 2026 Financial Results
Conference Call Today at 4:30 p.m. ET SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER)
EQUITY | Nov 16, 2026, 09:02 PM UTC
L
Wrap Technologies (WRAP) Nine-Month Revenue Rose 43%; Q3 Revenue Was $1.5M
Third-quarter 2026 revenue was $1.5M, consistent with the prior-year period. First-nine-month revenue increased 43% year over year, led by product sales.Material DetailsContext by AI AnalystThis is a quarterly results up
EARNINGS | Nov 16, 2026, 09:02 PM UTC
L
Omeros 3Q Loss/Shr 79c >OMER
Omeros 3Q Loss/Shr 79c >OMER
EQUITY | Nov 16, 2026, 09:02 PM UTC
L
Omeros 3Q Loss $57.4M >OMER
Omeros 3Q Loss $57.4M >OMER
EQUITY | Nov 16, 2026, 09:02 PM UTC
L
CervoMed Presents Interim Neflamapimod Biomarker Data at CTAD 2026
CervoMed said interim data show neflamapimod reduces a neurodegeneration biomarker in nonfluent variant primary progressive aphasia.
EQUITY | Nov 16, 2026, 09:02 PM UTC
L
Former BoC Deputy Governor Paul Beaudry Weighs Applying For Governor Job - BNN TV
Former BoC Deputy Governor Paul Beaudry Weighs Applying For Governor Job - BNN TV
NEWS | Nov 16, 2026, 09:02 PM UTC
L
OMEROS CORPORATION Q3 EPS USD -0.79
OMEROS CORPORATION Q3 EPS USD -0.79
EARNINGS | Nov 16, 2026, 09:02 PM UTC
L
BRIEF-Enanta Pharmaceuticals Q4 Revenue USD 12.868 Million
BRIEF-Enanta Pharmaceuticals Q4 Revenue USD 12.868 Million Nov 16 (Reuters) - Enanta Pharmaceuticals
EARNINGS | Nov 16, 2026, 09:02 PM UTC
L
BRIEF-Interpace Biosciences Q3 Revenue USD 10.373 Million
BRIEF-Interpace Biosciences Q3 Revenue USD 10.373 Million Nov 16 (Reuters) - Interpace Biosciences Q
EARNINGS | Nov 16, 2026, 09:02 PM UTC
L
OMEROS CORPORATION Q3 NET INCOME USD -57.4 MILLION
OMEROS CORPORATION Q3 NET INCOME USD -57.4 MILLION
FX | Nov 16, 2026, 09:02 PM UTC
L
OMEROS CORPORATION REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
OMEROS CORPORATION REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 16, 2026, 09:02 PM UTC
L
Arrow Electronics to Participate in UBS Global Technology and AI Conference
EQUITY | Nov 16, 2026, 09:02 PM UTC
L
Orezone Gold Reports Third Quarter 2026 Results
All dollar amounts are in USD unless otherwise indicatedVANCOUVER, British Columbia, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE | ASX: ORE | OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased
COMMODITIES | Nov 16, 2026, 09:01 PM UTC
L
Arrow Electronics Participates in UBS Technology and AI Conference
Arrow Electronics is participating in UBS’s technology and artificial intelligence conference.
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
WRAP Reports 43% Nine-Month Revenue Growth; Highlights Ongoing Congressional, ATF and State Actions Supporting Non-Lethal Response
WrapShield Advances Toward Commercialization with Frenel Engineering Milestone; Operationalizing De-Escalation Gains Traction with First State CertificationMIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc.
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
Arrow Electronics to Present at UBS Technology and AI Conference
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
Arrow Electronics Participates in UBS Technology and AI Conference
Arrow Electronics is participating in a UBS conference focused on technology and artificial intelligence.
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
Enanta CEO Jay Luly to Retire by February 2027
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
Daré Bioscience Reports Third Quarter 2026 Financial Results and Highlights Commercial Execution and Pipeline Advancement
DARE to PLAY™ Sildenafil Cream prescription dispensing activities underway this month, with prescriptions written across 48 states and Washington, D.C.Commercial launch of Flora Sync LF5™ showing encouraging early indica
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
Oil Settles Lower as Recovering Middle East Exports Bolster Surplus Outlook
ENERGY | Nov 16, 2026, 09:01 PM UTC
L
BrainStorm Cell Therapeutics Inc. (BCLI) Reports Q3 2026 Results; No Figures Provided
BrainStorm Cell Therapeutics announced financial results for the quarter ended September 30, 2026, but the release provides no financial figures. It said preparations continue for the Phase 3b ENDURANCE study of NurOwn i
EQUITY | Nov 16, 2026, 09:01 PM UTC
M
CBOT Soybeans Slip as Liquidation and Falling Crude Offset Strong Crush
CBOT soybeans sagged as liquidation and falling crude oil prices offset strong crush demand, Reuters reported.
COMMODITIES | Nov 16, 2026, 09:01 PM UTC
L
XP INC. Q3 GROSS REVENUE 5.3 BLN REAIS VS IBES ESTIMATE 5.1 BLN REAIS
XP INC. Q3 GROSS REVENUE 5.3 BLN REAIS VS IBES ESTIMATE 5.1 BLN REAIS
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
XP INC. Q3 GROSS REVENUE 5.3 BLN REAIS VS IBES ESTIMATE 5.1 BLN REAIS
XP INC. Q3 GROSS REVENUE 5.3 BLN REAIS VS IBES ESTIMATE 5.1 BLN REAIS
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
Lilly Receives Worldwide Rights to Develop and Commercialize Collaboration Products
Lilly received exclusive worldwide rights to develop and commercialize products arising from a collaboration with Stipple Bio.
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
XP INC. Q3 ADJUSTED NET PROFIT 1.38 BLN REAIS VS IBES ESTIMATE 1.42 BLN REAIS
XP INC. Q3 ADJUSTED NET PROFIT 1.38 BLN REAIS VS IBES ESTIMATE 1.42 BLN REAIS
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
BrainStorm Cell Therapeutics Announces Third Quarter 2026 Financial Results and Provides Corporate Update
NEW YORK, Nov. 16, 2026 // -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the third quarter e
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
XP INC. Q3 ADJUSTED NET PROFIT 1.38 BLN REAIS VS IBES ESTIMATE 1.42 BLN REAIS
XP INC. Q3 ADJUSTED NET PROFIT 1.38 BLN REAIS VS IBES ESTIMATE 1.42 BLN REAIS
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
Enanta Pharmaceuticals (ENTA) Reports FY2026 Net Loss of $68.2M
Enanta reported FY2026 revenue of $63.0M versus $65.3M in FY2025 and a net loss of $68.2M, or $2.35 per diluted share, versus $81.9M, or $3.84, in FY2025. Cash and marketable securities were $194.5M at September 30, 2026
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
Daré Bioscience Reports Third Quarter 2026 Financial Results and Highlights Commercial Execution and Pipeline Advancement
DARE to PLAY™ Sildenafil Cream prescription dispensing activities underway this month, with prescrip
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
Interpace Biosciences Announces Third Quarter 2026 Financial and Business Results
Q3 Revenue of $10.4 million Q3 Thyroid volume year-over-year increase of 7% Q3 Thyroid revenue year
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2026
Completed Enrollment in LOTUS, a Phase 2b Trial of Zelicapavir in Pediatric Patients with Respirator
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
U.S. Soybeans 96% Harvested
COMMODITIES | Nov 16, 2026, 09:01 PM UTC
L
BrainStorm Cell Therapeutics Announces Third Quarter 2026 Financial Results and Provides Corporate Update
NEW YORK, Nov. 16, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2026
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial results for its fisc
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
BRAINSTORM CELL THERAPEUTICS ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
BRAINSTORM CELL THERAPEUTICS ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE U
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
INTERPACE BIOSCIENCES Q3 NET INCOME USD -1.61 MILLION
INTERPACE BIOSCIENCES Q3 NET INCOME USD -1.61 MILLION
FX | Nov 16, 2026, 09:01 PM UTC
L
INTERPACE BIOSCIENCES Q3 REVENUE USD 10.373 MILLION
INTERPACE BIOSCIENCES Q3 REVENUE USD 10.373 MILLION
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
INTERPACE BIOSCIENCES Q3 OPERATING INCOME USD -2.4 MILLION
INTERPACE BIOSCIENCES Q3 OPERATING INCOME USD -2.4 MILLION
FX | Nov 16, 2026, 09:01 PM UTC
L
BRIEF-Orezone Q3 Adjusted EPS USD 0.04
Nov 16 (Reuters) - Orezone Q3 adjusted cash flow USD 71.1 million.
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
U.S. Cotton Harvest 77% Complete
U.S. cotton is 77% harvested.
COMMODITIES | Nov 16, 2026, 09:01 PM UTC
L
Enanta Pharmaceuticals 4Q Rev $12.9M >ENTA
Enanta Pharmaceuticals 4Q Rev $12.9M >ENTA
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
BRIEF-Wrap Technologies Q3 Revenue USD 1.5 Million
BRIEF-Wrap Technologies Q3 Revenue USD 1.5 Million Nov 16 (Reuters) - Wrap Technologies Q3 operating
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
BRIEF-Orezone Q3 Adjusted EPS USD 0.04
BRIEF-Orezone Q3 Adjusted EPS USD 0.04 Nov 16 (Reuters) - Orezone Q3 adjusted cash flow USD 71.1 mil
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
ENANTA PHARMACEUTICALS Q4 OPERATING INCOME USD -22.039 MILLION
ENANTA PHARMACEUTICALS Q4 OPERATING INCOME USD -22.039 MILLION
FX | Nov 16, 2026, 09:01 PM UTC
L
INTERPACE BIOSCIENCES Q3 GROSS PROFIT USD 7.18 MILLION
INTERPACE BIOSCIENCES Q3 GROSS PROFIT USD 7.18 MILLION
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
Dare Bioscience 3Q Loss/Shr 18c >DARE
Dare Bioscience 3Q Loss/Shr 18c >DARE
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
Enanta Pharmaceuticals 4Q Loss $23.7M >ENTA
Enanta Pharmaceuticals 4Q Loss $23.7M >ENTA
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL FOURTH QUARTER AND YEAR-ENDED SEPTEMBER 30, 2026
ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL FOURTH QUARTER AND YEAR-ENDED SEPTEM
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
INTERPACE BIOSCIENCES ANNOUNCES THIRD QUARTER 2026 FINANCIAL AND BUSINESS RESULTS
INTERPACE BIOSCIENCES ANNOUNCES THIRD QUARTER 2026 FINANCIAL AND BUSINESS RESULTS
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
DARÉ BIOSCIENCE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS COMMERCIAL EXECUTION AND PIPELINE ADVANCEMENT
DARÉ BIOSCIENCE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS COMMERCIAL EXECUTION AND
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
Enanta Pharmaceuticals 4Q Loss/Shr 81c >ENTA
Enanta Pharmaceuticals 4Q Loss/Shr 81c >ENTA
EQUITY | Nov 16, 2026, 09:01 PM UTC
L
BRIEF-Wrap Technologies Q3 Revenue USD 1.5 Million
Nov 16 (Reuters) - Wrap Technologies Q3 operating expenses USD 4.8 million.
EARNINGS | Nov 16, 2026, 09:01 PM UTC
L
ENANTA PHARMACEUTICALS Q4 REVENUE USD 12.868 MILLION
ENANTA PHARMACEUTICALS Q4 REVENUE USD 12.868 MILLION
EARNINGS | Nov 16, 2026, 09:01 PM UTC